KETTLIE DANIELS: Open Payments
NPI 1790775054 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$908 in 28 payments from 11 companies in 2025. Trend: 2023 $827 · 2024 $409 · 2025 $908
Food & beverage: $908
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 7 | $187 |
| Axsome Therapeutics, Inc. | 4 | $186 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $144 |
| Braeburn Inc. | 1 | $113 |
| Alkermes, Inc. | 3 | $76 |
| Otsuka America Pharmaceutical, Inc. | 4 | $73 |
| Vanda Pharmaceuticals Inc. | 3 | $47 |
| Janssen Pharmaceuticals, Inc | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Corium, LLC | 1 | $18 |
Products named: INGREZZA, Auvelity, CAPLYTA, BRIXADI, REXULTI, ARISTADA, FANAPT, SPRAVATO.
Industry payments across OH — which companies pay providers there.
